Prior to co-founding Mandl & Co. Jack was Associate Vice President for Corporate Development at Emory University and played key project executive roles with Mike Mandl in developing Drug Innovation Ventures at Emory, Emory Innovations, Emory Genetics Laboratory, Emory Sports Medicine Complex, and most recently Emory’s $50.9-million acquisition of 60 acres at Executive Park in Brookhaven, Georgia. Jack currently leads the asset management practice at Mandl & Co., LLC in corporate and real estate development and strategic project execution. Mandl & Co. partners with institutional executives to identify and inventory non-core assets, develop cogent plans, and provide execution support to unlock their economic value. Jack has held leadership and governance roles with Emory-affiliated public-private entities, including EGL Genetic Diagnostics, LLC; Emory Innovations, Inc.; EmTech, Inc. and T3 Labs, Inc. Under his leadership, each of these companies has engaged in non-traditional and non-academic enterprises with missions to support and enhance the broader goals of Emory and Georgia Tech (in the case of EmTech).